Profile: Surmodics, Inc. is a provider of drug delivery and surface modification technologies to the healthcare industry. We focus on cardiovascular disease, ophthalmology, pharmaceutical, in vitro diagnostics and clinical markets. We offer hydrophilic coatings for cardiac delivery systems, catheters, guide wires and cardiac rhythm management leads. We also provide in-vitro diagnostic assay components such as protein, BioFXr colorimetric and chemiluminescent substrates, secondary antibodies, accessory reagents, recombinant autoimmune antigens & CodeLinkr microarray slides. Our ophthalmic drug delivery options include, biodegradable drug-eluting coatings for use on devices such as I-vation™ intravitreal implants, fully biodegradable polymer implants, and micro particle injections.

The company was founded in 1979, has revenues of USD 50-100 Million, has ~220 employees and is ISO 9001, CE certified. NASDAQ:SRDX (SEC Filings)

FDA Registration Number: 3001374820